4.4 Article

Evaluation of virulence factors of Candida albicans isolated from HIV-positive individuals using HAART

期刊

ARCHIVES OF ORAL BIOLOGY
卷 66, 期 -, 页码 61-65

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.archoralbio.2016.02.004

关键词

Candida albicans; HIV; virulence factors; Exoenzyme

资金

  1. CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)
  2. CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
  3. FAPEMIG (Fundacao de Amparo a Pesquisa do estado de Minas Gerais) [APQ-00464-11]

向作者/读者索取更多资源

The colonization by Candida species is one of the most important factors related to the development of oral candidiasis in HIV-infected individuals. The aim of the study was to evaluate and discuss the phospholipase, proteinase, DNAse and haemolytic activities of Candida albicans isolated from the oral cavity of HIV individuals with high efficiency antiretroviral therapy. Seventy-five isolates of C. albicans obtained from saliva samples of patients with HIV and 41 isolates from HIV-negative individuals were studied. Haemolytic activity was determined in Sabouraud dextrose agar plates containing 3% glucose and 7% sheep red cells. Culture medium containing DNA base-agar, egg yolk, and bovine albumin were used to determine DNase, phospholipase and proteinase activities, respectively. All isolates from the HIV patients group had haemolytic activity, 98% showed phospholipase activity, 92% were positive for proteinase and 32% DNAse activity. Regarding the group of individios HIV negative, all 41 isolates presented hemolytic activity, 90.2% showed phospholipase and proteinase activity and 12.2% were positive for DNAse. The phospholipase activity was more intense for the group of HIV positive individuals. DNase production was more frequently observed in the group of HIV-positive individuals. The percentage of isolates having DNAse activity was also significantly different between the groups of patients not using any antiretroviral therapy, those using transcriptase inhibitors and those using transcriptase inhibitor and protease inhibitor in combination. (C) 2016 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据